Before recommending semaglutide, tirzepatide, or another medically supervised weight-loss strategy, a physician may review weight history, prior weight-loss attempts, BMI, waist circumference, body composition goals, A1C, fasting glucose, insulin-resistance risk, cholesterol, triglycerides, blood pressure, liver enzymes, fatty liver risk, kidney function, current medications, diabetes medication use, history of pancreatitis, gallbladder disease, gastrointestinal symptoms, thyroid history, protein intake, exercise habits, sleep quality, hormonal symptoms, inflammation-related concerns, side-effect tolerance, and long-term maintenance planning
The prospective meta-analysis protocol was registered on PROSPERO under protocol CRD420251012733
Cancer stem cells (CSCs) are a unique population of cancer cells featuring stem-cell like characteristics and based on growing evidence, they may start the development of PC as is the situation with other neoplasms
Many people tolerate it well